Windlas Biotech Limited (NSE:WINDLAS)
India flag India · Delayed Price · Currency is INR
859.00
-0.90 (-0.10%)
Jul 31, 2026, 3:29 PM IST

Windlas Biotech Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
664.56609.94581.87426.26380.89
Depreciation & Amortization
295.56268.84131.98121.66119.26
Other Amortization
11.8711.012.461.982.21
Loss (Gain) From Sale of Assets
--0.09-0.06-8.76-0.1
Asset Writedown & Restructuring Costs
---0.08-
Loss (Gain) From Sale of Investments
-147.61-150.79-108.21-47.82-17.24
Stock-Based Compensation
166.1124.620.6710.0818.13
Provision & Write-off of Bad Debts
8.93127.4922.753.48
Other Operating Activities
86.228.28-6.1320.22-39.65
Change in Accounts Receivable
-610.29-308.03-198.35-83.63-316.73
Change in Inventory
195.6-191.95125.49-160.28-172.49
Change in Accounts Payable
606.54357.26437.68245.12233.04
Change in Other Net Operating Assets
-228.1551.874.7161.99-119.5
Operating Cash Flow
1,049681.871,090609.6591.3
Operating Cash Flow Growth
53.89%-37.42%78.72%567.74%-20.29%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-676.64-521.94-376.84-708.9-148.04
Sale of Property, Plant & Equipment
-1.970.429.11.1
Investment in Securities
-254.51-236.94-561.67513.2-1,424
Other Investing Activities
13.2416.2717.4145.525.62
Investing Cash Flow
-917.91-740.64-920.68-141.1-1,546

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
27.58270.08---
Total Debt Issued
27.58270.08---
Short-Term Debt Repaid
---2.26-53.42-248.07
Long-Term Debt Repaid
-28.52-145.44-16.33-16.52-9.05
Total Debt Repaid
-28.52-145.44-18.59-69.94-257.12
Net Debt Issued (Repaid)
-0.94124.64-18.59-69.94-257.12
Issuance of Common Stock
----1,650
Repurchase of Common Stock
---40.23-271.93-
Common Dividends Paid
-121.56-114.95-83.01-76.28-
Other Financing Activities
-7.820.44-11.07-19.24-92
Financing Cash Flow
-130.3210.13-152.9-437.391,301

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
1.11-48.6416.0231.16-153.6

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
372.7159.93712.76-99.25-56.74
Free Cash Flow Growth
133.04%-77.56%---
Free Cash Flow Margin
4.12%2.10%11.30%-1.93%-1.22%
Free Cash Flow Per Share
17.477.5734.15-4.59-2.77
Levered Free Cash Flow
297.8368.11629.88-124.53-167.52
Unlevered Free Cash Flow
327.9995.5636.79-119.6-158.67

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
48.2643.8211.077.8714.15
Cash Income Tax Paid
151.52208.84186.4897.1688.8
Change in Working Capital
-36.3-90.92439.5363.2-375.68